Astrana Health, Inc. (NASDAQ:ASTH) Stock Has Average Price Target of $49.88 According to Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given an average recommendation of “Moderate Buy” by the ten brokerages that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $49.88.

Several brokerages recently commented on ASTH. Barclays raised their price objective on Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. Wall Street Zen cut Astrana Health from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. BTIG Research increased their price target on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Truist Financial increased their price target on Astrana Health from $47.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astrana Health in a research report on Thursday, August 27th.

Astrana Health Trading Up 8.0%

ASTH opened at $39.67 on Monday. The firm’s fifty day moving average is $37.05 and its two-hundred day moving average is $33.92. The firm has a market cap of $2.21 billion, a PE ratio of 48.38 and a beta of 1.18. Astrana Health has a twelve month low of $18.08 and a twelve month high of $51.60. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.46. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The company had revenue of $972.52 million during the quarter, compared to analyst estimates of $985.62 million. During the same quarter in the previous year, the business earned $0.19 EPS. The firm’s revenue was up 48.5% on a year-over-year basis. Equities research analysts anticipate that Astrana Health will post 1.36 EPS for the current year.

Institutional Trading of Astrana Health

Large investors have recently bought and sold shares of the business. Farther Finance Advisors LLC increased its position in shares of Astrana Health by 730.1% during the third quarter. Farther Finance Advisors LLC now owns 689 shares of the company’s stock worth $25,000 after acquiring an additional 606 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in Astrana Health in the 2nd quarter valued at $51,000. Simplicity Wealth LLC bought a new stake in Astrana Health in the 3rd quarter valued at $296,000. Fifth Third Bancorp lifted its position in Astrana Health by 4,855.4% in the 1st quarter. Fifth Third Bancorp now owns 12,438 shares of the company’s stock valued at $305,000 after acquiring an additional 12,187 shares in the last quarter. Finally, Sterling Capital Management LLC boosted its stake in Astrana Health by 17.2% in the 3rd quarter. Sterling Capital Management LLC now owns 9,269 shares of the company’s stock worth $330,000 after purchasing an additional 1,359 shares during the period. 52.77% of the stock is owned by institutional investors.

About Astrana Health

Astrana Health, Inc (NASDAQ: ASTH), formerly known as Apollo Medical Holdings, is a healthcare enablement company focused on helping providers and health plans deliver coordinated, value-based care. The company combines physician networks, care-management capabilities, technology and data analytics to support improved clinical outcomes and more efficient healthcare delivery.

Astrana Health’s services include population health management, physician practice support, utilization management, care coordination and clinical analytics.